About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 542 record(s)
Req # A-2022-000007
Adverse Drug Reactions (ADRs). Report numbers: E2B_04699613, E2B_04699614, E2B_04699620, E2B_04699634, E2B_04699680, E2B_04699715, E2B_04699930, E2B_04702507, E2B_04703783, E2B_04703892.Organization: Health Canada
July 2022
Req # A-2022-000008
Adverse Drug Reactions (ADRs). Report numbers: E2B_04762423, E2B_04768605, E2B_04768415, E2B_04774061, E2B_04753198, E2B_04761665, E2B_04749605, E2B_04785592, E2B_04786962, E2B_04785598.Organization: Health Canada
July 2022
Req # A-2022-000018
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100949-338.Organization: Health Canada
July 2022
Req # A-2022-000031
Adverse Drug Reactions (ADRs). Report numbers: E2B_03034097, E2B_03034094, E2B_03092558, E2B_03104218, E2B_03344013, 000925935, E2B_03494144, E2B_03631159, E2B_03683732, E2B_03698133.Organization: Health Canada
July 2022
Req # A-2022-000033
Adverse Drug Reactions (ADRs). Report numbers: 000977179, E2B_03743349, 000951284.Organization: Health Canada
July 2022
Req # A-2022-000037
Adverse Drug Reactions (ADRs) for RANITIDINE HYDROCHLORIDE, IRBESARTAN, CLOPIDOGREL BISULFATE. Report numbers: E2B_01687167, E2B_01270122, E2B_03570635, E2B_04694587, E2B_04651222.Organization: Health Canada
July 2022
Req # A-2022-000038
Adverse Drug Reactions (ADRs) for INSULIN GLARGINE, SARILUMAB, ZOPICLONE, DUPILUMAB. Report numbers: 000971525, 000967779, E2B_04683043, E2B_04709100, E2B_04694208.Organization: Health Canada
July 2022
Req # A-2022-000041
Adverse Drug Reactions (ADRs) for Zostavax II. Report numbers: E2B_01742359, E2B_01747192, E2B_02271205, E2B_02307576, E2B_02162521, E2B_00719137, E2B_00890322, E2B_02157290, E2B_02548174, E2B_02464454.Organization: Health Canada
July 2022
Req # A-2022-000044
Adverse Drug Reaction (ADR) for Zostavax II. Report number: E2B_02235603.Organization: Health Canada
July 2022
Req # A-2022-000045
Adverse Drug Reactions (ADRs) for ZOSTAVAX II. Report numbers: E2B_02321852, E2B_02456455, E2B_02559448, E2B_00399116. ADR for BRIDION. Report number: 000737460. ADRs for CANCIDAS. Report numbers: E2B_02786566, E2B_02790699, E2B_02233985.Organization: Health Canada
July 2022